Aceragen, Inc. Sustainability Profile
Aceragen, Inc., a prominent biotechnology firm headquartered in the United States, is dedicated to advancing innovative therapies for rare diseases. Founded in 2018, the company has quickly established itself in the biopharmaceutical industry, focusing on the development of transformative treatments that address unmet medical needs. With a strong operational presence across key regions in the US, Aceragen is committed to harnessing cutting-edge science to create unique products that enhance patient outcomes. Their core offerings include novel therapeutics designed to target specific genetic disorders, setting them apart in a competitive market. Recognised for its rapid growth and commitment to research excellence, Aceragen continues to make significant strides in the biotechnology landscape, positioning itself as a leader in the quest for effective solutions for rare diseases.
DitchCarbon Score
How does Aceragen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Aceragen, Inc.'s score of 17 is lower than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Aceragen, Inc.'s reported carbon emissions
Aceragen, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Aceragen may still be in the early stages of developing a comprehensive climate strategy. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate their environmental impact. However, without specific commitments or data, it is challenging to assess Aceragen's position relative to its peers in terms of carbon emissions and climate action.
How Carbon Intensive is Aceragen, Inc.'s Industry?
How Carbon Intensive is Aceragen, Inc.'s Location?
Aceragen, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Aceragen, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
